These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23761833)

  • 41. Inflammatory myofibroblastic tumor of the lung in pregnancy mimicking carcinoid tumor.
    Maturu VN; Bal A; Singh N
    Lung India; 2016; 33(1):82-4. PubMed ID: 26933315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects.
    Brivio E; Zwaan CM
    Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.
    Mamesaya N; Nakashima K; Naito T; Nakajima T; Endo M; Takahashi T
    BMC Cancer; 2017 Jul; 17(1):471. PubMed ID: 28683775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory Myofibroblastic Tumor of the Tongue. Report of a Pediatric Case and Review of the Literature.
    Caporalini C; Moscardi S; Tamburini A; Pierossi N; Di Maurizio M; Buccoliero AM
    Fetal Pediatr Pathol; 2018 Apr; 37(2):117-125. PubMed ID: 29336647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
    Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
    Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.
    Butrynski JE; D'Adamo DR; Hornick JL; Dal Cin P; Antonescu CR; Jhanwar SC; Ladanyi M; Capelletti M; Rodig SJ; Ramaiya N; Kwak EL; Clark JW; Wilner KD; Christensen JG; Jänne PA; Maki RG; Demetri GD; Shapiro GI
    N Engl J Med; 2010 Oct; 363(18):1727-33. PubMed ID: 20979472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Rare Case of Inflammatory Myofibroblastic Tumor of the Prostate and Review of the Literature.
    Kim MS; Lim SC
    In Vivo; 2020; 34(4):2043-2048. PubMed ID: 32606180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
    Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
    Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Comparative Study of Inflammatory Myofibroblastic Tumors and Tumefactive IgG4-related Inflammatory Lesions: the Relevance of IgG4 Plasma Cells.
    Chougule A; Bal A; Das A; Agarwal R; Singh N; Rao KL
    Appl Immunohistochem Mol Morphol; 2016; 24(10):721-728. PubMed ID: 26469330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from India.
    Patel A; Batra U; Prasad KT; Dabkara D; Ghosh J; Sharma M; Singh N; Suresh P; Jain P; Malik PS; Choudhary P; Ganguly S; Khurana S; Ms S; Bothra S; Muthu V; Biswas B
    Curr Probl Cancer; 2020 Jun; 44(3):100571. PubMed ID: 32234264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review.
    Watanabe J; Togo S; Sumiyoshi I; Namba Y; Suina K; Mizuno T; Kadoya K; Motomura H; Iwai M; Nagaoka T; Sasaki S; Hayashi T; Uekusa T; Abe K; Urata Y; Sakurai F; Mizuguchi H; Kato S; Takahashi K
    Oncotarget; 2018 May; 9(35):24000-24013. PubMed ID: 29844868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
    Mossé YP; Voss SD; Lim MS; Rolland D; Minard CG; Fox E; Adamson P; Wilner K; Blaney SM; Weigel BJ
    J Clin Oncol; 2017 Oct; 35(28):3215-3221. PubMed ID: 28787259
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Michels SYF; Scheel AH; Wündisch T; Heuckmann JM; Menon R; Puesken M; Kobe C; Pasternack H; Heydt C; Scheffler M; Fischer R; Schultheis AM; Merkelbach-Bruse S; Heukamp L; Büttner R; Wolf J
    NPJ Precis Oncol; 2017; 1(1):4. PubMed ID: 29872693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: A case report and review of the literature.
    Kim S; Bakkum-Gamez JN; Okuno S; Kerr S; Dowdy SC
    Gynecol Oncol Rep; 2015 Apr; 12():9-12. PubMed ID: 26076149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor.
    Jacob SV; Reith JD; Kojima AY; Williams WD; Liu C; Vila Duckworth L
    Case Rep Pathol; 2014; 2014():470340. PubMed ID: 25045570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors.
    Trahair T; Gifford AJ; Fordham A; Mayoh C; Fadia M; Lukeis R; Wood AC; Valvi S; Walker RD; Blackburn J; Heyer EE; Mercer TR; Barbaric D; Marshall GM; MacKenzie KL
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracranial Inflammatory Myofibroblastic Tumor with Negative Expression of Anaplastic Lymphoma Kinase: A Case Report and Review of the Literature.
    Wang X; Chen Y; Wu X; Zhang H
    World Neurosurg; 2019 May; 125():117-122. PubMed ID: 30735872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.